The Tyrosinemia Type I
Martin Nelwan
Abstract
Open-access reader
Martin Nelwan
Abstract
Open-access reader
Tyrosinemia type 1 is an autosomal recessive disorder which can be detected as early as possible after birth so that it may be treated or alleviated immediately. If untreated, the disorder can cause dysfunctions of liver, kidney, or neurological disease. There are 3 kinds of tyrosinemia; that is, tyrosinemia type 1, 2, and 3. Tyrosinemia type 1 is the most severe of these disorders. To treat or alleviate the disorder, it can be performed using nitisinone drug along with diet management and liver transplantation. Other methods, which may be used to reduce tyrosinemia type 1, are gene therapy, and, of course, genetic counseling.
A significance statement is not available in the OpenAlex record.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Tyrosinemia type 1 is an autosomal recessive disorder which can be detected as early as possible after birth so that it may be treated or alleviated immediately. If untreated, the disorder can cause dysfunctions of liver, kidney, or neurological disease. There are 3 kinds of tyrosinemia; that is, tyrosinemia type 1, 2, and 3. Tyrosinemia type 1 is the most severe of these disorders. To treat or alleviate the disorder, it can be performed using nitisinone drug along with diet management and liver transplantation. Other methods, which may be used to reduce tyrosinemia type 1, are gene therapy, and, of course, genetic counseling.
Key concepts: Tyrosinemia, Medicine, Liver transplantation, Genetic counseling, Internal medicine, Pediatrics, Endocrinology, Transplantation